← Back to the wire

J&J to Pay $5.5 Billion to Resolve Talc-Related Cancer Claims

Legal·2 articles across 2 outlets

Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data

Johnson & Johnson on Monday said it agreed to a $5.5 billion commitment to resolve litigation related to claims that its talc products caused ovarian cancer.

The settlement aims to address numerous lawsuits alleging that the company's talc products were linked to cancer, providing a significant financial resolution to ongoing legal challenges.

Johnson & Johnson

Sources

Every quote below is verbatim from the article it is attributed to.

SourceReports the news
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.